Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetesBradford S. Hamilton, Gerard M. McGeehan, Herbert Nar et al.|European Journal of Pharmacology|2014Cited by 29